News

Sun Pharma says working towards full regulatory resolution at 3 plants facing USFDA action
Sun Pharma aims to enhance compliance and R&D investment for global speciality products, targeting mid to high single-digit ...
Rediff Money23m
Sun Pharma Addresses USFDA Issues at 3 Plants
Sun Pharma is working to resolve USFDA compliance issues at three facilities: Halol, Mohali, and Dadra. The company is implementing CAPA and anticipates mid to high single-digit growth in FY26.
Eli Lilly's 3-step strategy to dominate the $95 billion obesity market
Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...
Obesity drug prices are dropping, but getting a steady supply remains a challenge
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging.
10 Menopause Myths the Experts Can’t Stand
Hot flashes are a menopausal hallmark: Up to 80 percent of women have them. But numerous lesser-known symptoms are also ...
FDA Layoffs Could Compromise Safety of Medications Made at Foreign Factories, Inspectors Say
Victoria Malis, Katherine Dailey and Sadie Leite, Medill Investigative Lab, and Debbie Cenziper and Megan Rose, ProPublica ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up ...